For example, NAT10 promotes a mediator for DNA damage checkpoint activation, MORC2 K767Ac, and thus is considered a promising target for sensitizing breast cancer cells to DNA-damaging chemotherapy and radiotherapy (18). This evidence concerns the gene MORC2 and breast carcinoma.